High-flow nasal cannula oxygen reduced hypoxemia in patients undergoing gastroscopy under general anesthesia at ultra-high altitude: a randomized controlled trial

Dunzhu Zhaxi,Deji Ci,Xiang Quan,Ciren Laba

DOI: https://doi.org/10.1186/s12871-024-02568-9

IF: 2.376

2024-05-29

BMC Anesthesiology

Abstract:Hypoxemia can occur in people at ultra-high altitude (above 3500 m) even at rest, and patients undergoing gastroscopy under general anesthesia have higher risk of hypoxemia. Supplementary oxygen via standard nasal cannula (SNC) is the standard of care for most patients who undergo gastroscopy under general anesthesia, which provides oxygen flow up to 15 L/min. High-flow nasal cannula (HFNC) could deliver oxygen at a rate up to 60 L/min, which is recommended by the American Society of Anesthesiologists Practice Guidelines. We speculated that the benefit with HFNC is more prominent in high-altitude areas, and aimed to compare the incidence of hypoxemia during gastroscopy under general anesthesia at ultra-high altitude with oxygen supply via either HFNC or SNC.

anesthesiology

What problem does this paper attempt to address?

The aim of this paper is to address the issue of the higher risk of hypoxemia in patients undergoing general anesthesia for gastroscopy in ultra-high altitude areas (altitudes above 3500 meters). The study compared the effects of using high-flow nasal cannula (HFNC) versus standard nasal cannula (SNC) on the incidence of hypoxemia during general anesthesia for gastroscopy in ultra-high altitude areas. The study hypothesized that HFNC would be more effective at high altitudes and tested this hypothesis through a randomized controlled trial. Specifically, the primary outcome measure of the study was the incidence of hypoxemia (SpO2 < 90%) during anesthesia, while secondary outcome measures included the incidence of severe hypoxemia (SpO2 < 75% or duration ≥ 60 seconds) and hypotension.